FR2645455B2 - Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees et utilisation en pharmacie ou en cosmetologie sous forme de compositions pharmaceutiques ou cosmetiques - Google Patents

Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees et utilisation en pharmacie ou en cosmetologie sous forme de compositions pharmaceutiques ou cosmetiques

Info

Publication number
FR2645455B2
FR2645455B2 FR8904762A FR8904762A FR2645455B2 FR 2645455 B2 FR2645455 B2 FR 2645455B2 FR 8904762 A FR8904762 A FR 8904762A FR 8904762 A FR8904762 A FR 8904762A FR 2645455 B2 FR2645455 B2 FR 2645455B2
Authority
FR
France
Prior art keywords
liposomes
phases
hydrated lipid
lamid
cosmetology
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8904762A
Other languages
English (en)
Other versions
FR2645455A2 (fr
Inventor
Alain Huc
Chantal Buffevant
Daniel Herbage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Bioetica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8714632A external-priority patent/FR2622104B1/fr
Priority to CA000584886A priority Critical patent/CA1330650C/fr
Application filed by Bioetica SA filed Critical Bioetica SA
Priority to FR8904762A priority patent/FR2645455B2/fr
Priority to DK90400967.7T priority patent/DK0397542T3/da
Priority to ES199090400967T priority patent/ES2034831T3/es
Priority to AT90400967T priority patent/ATE78156T1/de
Priority to EP90400967A priority patent/EP0397542B1/fr
Priority to JP2096141A priority patent/JPH0734858B2/ja
Priority to DE9090400967T priority patent/DE69000194T2/de
Publication of FR2645455A2 publication Critical patent/FR2645455A2/fr
Priority to US07/788,481 priority patent/US5244672A/en
Priority to GR920402239T priority patent/GR3005919T3/el
Publication of FR2645455B2 publication Critical patent/FR2645455B2/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FR8904762A 1987-10-22 1989-04-11 Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees et utilisation en pharmacie ou en cosmetologie sous forme de compositions pharmaceutiques ou cosmetiques Expired - Lifetime FR2645455B2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CA000584886A CA1330650C (fr) 1987-10-22 1988-12-02 Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees par un emploi d'un support stabilisant a base d'atelocollagene et de glycosaminoglycannes, et utilisation en pharmacie ou en ...
FR8904762A FR2645455B2 (fr) 1987-10-22 1989-04-11 Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees et utilisation en pharmacie ou en cosmetologie sous forme de compositions pharmaceutiques ou cosmetiques
JP2096141A JPH0734858B2 (ja) 1988-12-02 1990-04-10 水和脂質薄相の安定化方法、安定化水和脂質薄相組成物、ならびにそれを含む医薬組成物および化粧料組成物
ES199090400967T ES2034831T3 (es) 1988-12-02 1990-04-10 Procedimiento de estabilizacion para fases lamelares hidratadas.
AT90400967T ATE78156T1 (de) 1988-12-02 1990-04-10 Stabilisierung von hydratierten lamellaren phasen.
EP90400967A EP0397542B1 (fr) 1988-12-02 1990-04-10 Stabilisation de phases lamellaires hydratées
DK90400967.7T DK0397542T3 (da) 1988-12-02 1990-04-10 Stabiliseringsfremgangsmåde for hydratiserede lamellare faser
DE9090400967T DE69000194T2 (de) 1988-12-02 1990-04-10 Stabilisierung von hydratierten lamellaren phasen.
US07/788,481 US5244672A (en) 1988-12-02 1991-11-06 Composition containing liposomes stabilized by a stabilizing support based on atelocollagen and glycosaminoglycans
GR920402239T GR3005919T3 (fr) 1988-12-02 1992-10-08

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8714632A FR2622104B1 (fr) 1987-10-22 1987-10-22 Procede de stabilisation de phases lamellaires lipidiques hydratees, par ex. de liposomes, composition de phases lamellaires lipidiques hydratees, par ex. des liposomes, stabilisees par un emploi d'un support stabilisant a base d'atelocollagene et de glycosaminoglycannes et utilisation en pharmacie ou en cosmetologie
CA000584886A CA1330650C (fr) 1987-10-22 1988-12-02 Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees par un emploi d'un support stabilisant a base d'atelocollagene et de glycosaminoglycannes, et utilisation en pharmacie ou en ...
FR8904762A FR2645455B2 (fr) 1987-10-22 1989-04-11 Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees et utilisation en pharmacie ou en cosmetologie sous forme de compositions pharmaceutiques ou cosmetiques

Publications (2)

Publication Number Publication Date
FR2645455A2 FR2645455A2 (fr) 1990-10-12
FR2645455B2 true FR2645455B2 (fr) 1994-04-08

Family

ID=27168120

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8904762A Expired - Lifetime FR2645455B2 (fr) 1987-10-22 1989-04-11 Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees et utilisation en pharmacie ou en cosmetologie sous forme de compositions pharmaceutiques ou cosmetiques

Country Status (2)

Country Link
CA (1) CA1330650C (fr)
FR (1) FR2645455B2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61154567A (ja) * 1984-12-26 1986-07-14 生化学工業株式会社 架橋グリコサミノグリカン複合体
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
JPS61191364A (ja) * 1985-02-21 1986-08-26 工業技術院長 抗血栓性材料

Also Published As

Publication number Publication date
FR2645455A2 (fr) 1990-10-12
CA1330650C (fr) 1994-07-12

Similar Documents

Publication Publication Date Title
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
GB2247837B (en) Pharmaceutical product for the treatment of immunoregulatory disorders
EP1049459A4 (fr) Compositions liquides orales
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
GB9218278D0 (en) Three-phase lotion suitable for pharmaceutical or cosmetic bodily use
HUT59138A (en) Process for producing carbocyclic adenosine analogs and pharmaceutical compositions comprising same as active ingredient
HUP0100024A3 (en) Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
IL108712A0 (en) Pharmaceutical composition for the treatment of androgen-associated baldness comprising antisense oligomers
IL106472A0 (en) Hydroxamic acid derivatives,their preparation and pharmaceutical compositions containing them
HUT49598A (en) Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
IL94525A0 (en) Pharmaceutical compositions comprising bmy 14802 for treating ischemic and degenerative brain disorders
HUT47233A (en) Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients
HUT48232A (en) Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT53109A (en) Process for producing benzodiazepine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
FR2645455B2 (fr) Procede de stabilisation de phases lamellaires lipidiques hydratees, par exemple de liposomes, composition de phases lamellaires lipidiques hydratees, par exemple des liposomes, stabilisees et utilisation en pharmacie ou en cosmetologie sous forme de compositions pharmaceutiques ou cosmetiques
HU9700989D0 (en) Ortho-substituted benzoyl-guanidines, process for producing them, their use as medicament and diagnosticment, pharmaceutical compositions containing them
FR2622104B1 (fr) Procede de stabilisation de phases lamellaires lipidiques hydratees, par ex. de liposomes, composition de phases lamellaires lipidiques hydratees, par ex. des liposomes, stabilisees par un emploi d'un support stabilisant a base d'atelocollagene et de glycosaminoglycannes et utilisation en pharmacie ou en cosmetologie
ES2034831T3 (es) Procedimiento de estabilizacion para fases lamelares hidratadas.
HRP940315B1 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
IT1184729B (it) Prodotti farmaceutico cosmetico,in particolare per la cura di acne e seborrea

Legal Events

Date Code Title Description
CD Change of name or company name